Xlife Sciences AG/ CH0461929603 /
2024-10-11 4:55:38 PM | Chg. -7.70 | Volume | Bid5:20:00 PM | Ask2024-10-08 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
25.10CHF | -23.48% | 135 Turnover: 3,396 |
-Bid Size: - | -Ask Size: - | 139.81 mill.CHF | - | 9.16 |
Newsfile Corp
3:22 AM
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Endava
Newsfile Corp
2:03 AM
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Metagenomi, Inc. Investors to Secure Counsel Before I...
Newsfile Corp
1:07 AM
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages DexCom, Inc. Investors to Secure Counsel Before Impor...
Newsfile Corp
1:04 AM
CXM DEADLINE: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Sprinklr, Inc. Investors with Losses in E...
Newsfile Corp
12:43 AM
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Iris Energy Limited Investors to Secure Counsel Before ...
Newsfile Corp
12:36 AM
SEE Shines at New York Climate Week, Highlighting Progressive Climate Solutions In China
Newsfile Corp
12:27 AM
ROSEN, A TOP RANKED LAW FIRM, Encourages Domino's Pizza, Inc. Investors to Secure Counsel Before Imp...
Newsfile Corp
12:16 AM
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Allarity Therapeutics, Inc. Investors to Secure Counsel Be...
Newsfile Corp
12:14 AM
ARDX DEADLINE ALERT: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Ardelyx, Inc. Investors to Secur...